We are live on ! Find out more
SRGA

Surgalign Holdings, Inc. Common Stock

Delisted

SRGA was delisted on the 30th of June, 2023.

95 hedge funds and large institutions have $161M invested in Surgalign Holdings, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 43 increasing their positions, 23 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

87% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 23

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

9% more capital invested

Capital invested by funds: $148M → $161M (+$13.3M)

12% less funds holding

Funds holding: 10895 (-13)

43% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 14

Holders
95
Holders Change
-13
Holders Change %
-12.04%
% of All Funds
2.36%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
8
Increased
43
Reduced
23
Closed
14
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
PCMI
1
Paradigm Capital Management Inc
New York
$23.3M +$722K +6,940 +4%
BlackRock
2
BlackRock
New York
$20.6M +$17.8M +170,949 +26,921%
KAM
3
Krensavage Asset Management
New York
$17.8M +$770K +7,400 +5%
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$15.6M +$260K +2,498 +2%
HC
5
Hillman Company
Pennsylvania
$10.7M
Vanguard Group
6
Vanguard Group
Pennsylvania
$7.72M +$29.2K +281 +0.4%
RSCM
7
Rock Springs Capital Management
Maryland
$7.44M
KCM
8
Kennedy Capital Management
Missouri
$5.69M +$822K +7,897 +20%
FP
9
Foundry Partners
Minnesota
$4.16M +$181K +1,737 +5%
State Street
10
State Street
Massachusetts
$4.07M +$71.5K +687 +2%
D.E. Shaw & Co
11
D.E. Shaw & Co
New York
$4.03M +$31.7K +305 +0.9%
KIA
12
Kopp Investment Advisors
Minnesota
$3.27M +$354K +3,400 +14%
Renaissance Technologies
13
Renaissance Technologies
New York
$3.04M +$294K +2,824 +13%
RA
14
Royce & Associates
New York
$2.88M -$201K -1,934 -7%
Northern Trust
15
Northern Trust
Illinois
$2.6M +$50K +480 +2%
2L
16
22NW LP
Washington
$2.39M +$2.5K +24 +0.1%
BCM
17
Bridgeway Capital Management
Texas
$2M +$1.5M +14,379 +616%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$1.82M +$56.4K +542 +4%
Morgan Stanley
19
Morgan Stanley
New York
$1.07M -$348K -3,340 -27%
GS
20
Gagnon Securities
New York
$1.06M +$15.5K +149 +2%
Bank of New York Mellon
21
Bank of New York Mellon
New York
$1.02M +$30.1K +289 +4%
AA
22
Ancora Advisors
Ohio
$984K +$121K +1,167 +17%
TCIM
23
TIAA CREF Investment Management
New York
$891K +$70.5K +677 +10%
California Public Employees Retirement System
24
California Public Employees Retirement System
California
$874K +$85.3K +820 +13%
Victory Capital Management
25
Victory Capital Management
Texas
$873K -$150K -1,438 -17%

SRGA Hedge Fund Activity: Q1 2017 in Review

95 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Surgalign Holdings, Inc. Common Stock (SRGA) for Q1 2017, worth a combined $161M — up 9% from $148M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of SRGA and 8 opened new positions — a net loss of 6 holders — while 23 trimmed existing stakes and 43 added.

The largest buyer was BlackRock, adding an estimated $17.8M. The largest seller was First Light Asset Management, exiting entirely with an estimated $1.65M sold.

  • 95 institutional investors held Surgalign Holdings, Inc. Common Stock (SRGA) as of Q1 2017, down from 108 in Q4 2016.
  • Funds reported $161M of Surgalign Holdings, Inc. Common Stock stock for Q1 2017, up 9% quarter-over-quarter.
  • 8 funds opened new Surgalign Holdings, Inc. Common Stock positions in Q1 2017 and 14 closed out, a net change of -6 holders.
  • The largest Surgalign Holdings, Inc. Common Stock buyer in Q1 2017 was BlackRock, an estimated $17.8M added.
  • The largest Surgalign Holdings, Inc. Common Stock seller in Q1 2017 was First Light Asset Management, an estimated $1.65M sold.

Based on aggregated 13F filings for Q1 2017.